[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100603545":3},{"organization":4,"armGroups":7,"interventions":21,"overallOfficials":31,"centralContacts":38,"locations":44,"responsibleParty":180,"collaborators":11,"id":182,"slug":183,"hasResults":184,"nctId":185,"briefTitle":186,"officialTitle":187,"acronym":11,"eligibilityCriteria":188,"healthyVolunteers":184,"sex":189,"minAge":190,"maxAge":191,"enrollmentInfo":192,"targetDuration":11,"studyType":195,"phases":196,"briefSummary":198,"conditions":199,"keywords":201,"overallStatus":47,"whyStopped":11,"lastUpdateSubmitDate":203,"lastUpdatePostDateStruct":204,"startDateStruct":207,"completionDateStruct":209,"leadSponsor":211,"locationsCount":212},{"fullName":5,"class":6},"Ausper Biopharma Co., Ltd.","INDUSTRY",[8,15,18],{"label":9,"type":10,"description":11,"interventionNames":12},"Part A: AHB-137 With NA Therapy","EXPERIMENTAL",null,[13,14],"Drug: AHB-137","Drug: NA therapy",{"label":16,"type":10,"description":11,"interventionNames":17},"Part B: AHB-137 with NA Therapy",[13,14],{"label":19,"type":10,"description":11,"interventionNames":20},"Part B: AHB-137 Without NA Therapy",[13],[22,27],{"type":23,"name":24,"description":25,"armGroupLabels":26,"otherNames":11},"DRUG","AHB-137","AHB-137 will be injected",[9,19,16],{"type":23,"name":28,"description":29,"armGroupLabels":30,"otherNames":11},"NA therapy","NA will be usede.",[9,16],[32,36],{"name":33,"affiliation":34,"role":35},"Junqi Niu","The First Hospital of Jilin University","PRINCIPAL_INVESTIGATOR",{"name":37,"affiliation":34,"role":35},"Yanhua Ding",[39],{"name":40,"role":41,"phone":42,"phoneExt":11,"email":43},"Lu","CONTACT","0571-86959519","clinicaltrial@ausperbio.com",[45,62,72,86,95,105,116,126,136,147,158,169],{"facility":46,"status":47,"city":48,"state":49,"zip":11,"country":50,"countryCode":51,"cosmosGeoPoint":52,"geoPoint":57,"contacts":58},"AusperBio Investigational Site","RECRUITING","Beijing","Beijing Municipality","China","CN",{"type":53,"coordinates":54},"Point",[55,56],116.39723,39.9075,{"lat":56,"lon":55},[59,61],{"name":40,"role":41,"phone":60,"phoneExt":11,"email":43},"057186959519",{"name":11,"role":41,"phone":11,"phoneExt":11,"email":43},{"facility":46,"status":47,"city":63,"state":64,"zip":11,"country":50,"countryCode":51,"cosmosGeoPoint":65,"geoPoint":69,"contacts":70},"Jilin City","Changchun",{"type":53,"coordinates":66},[67,68],126.5608,43.84652,{"lat":68,"lon":67},[71],{"name":40,"role":41,"phone":42,"phoneExt":11,"email":43},{"facility":46,"status":73,"city":74,"state":75,"zip":11,"country":50,"countryCode":51,"cosmosGeoPoint":76,"geoPoint":80,"contacts":81},"NOT_YET_RECRUITING","Chongqing","Chongqing Municipality",{"type":53,"coordinates":77},[78,79],106.55771,29.56026,{"lat":79,"lon":78},[82,83,84],{"name":40,"role":41,"phone":60,"phoneExt":11,"email":43},{"name":11,"role":41,"phone":11,"phoneExt":11,"email":43},{"name":85,"role":35,"phone":11,"phoneExt":11,"email":11},"Xuan An",{"facility":46,"status":73,"city":74,"state":75,"zip":11,"country":50,"countryCode":51,"cosmosGeoPoint":87,"geoPoint":89,"contacts":90},{"type":53,"coordinates":88},[78,79],{"lat":79,"lon":78},[91,92,93],{"name":40,"role":41,"phone":60,"phoneExt":11,"email":43},{"name":11,"role":41,"phone":11,"phoneExt":11,"email":43},{"name":94,"role":35,"phone":11,"phoneExt":11,"email":11},"Hu Peng",{"facility":46,"status":47,"city":96,"state":97,"zip":11,"country":50,"countryCode":51,"cosmosGeoPoint":98,"geoPoint":102,"contacts":103},"Xiamen","Fujian",{"type":53,"coordinates":99},[100,101],118.08187,24.47979,{"lat":101,"lon":100},[104],{"name":40,"role":41,"phone":60,"phoneExt":11,"email":43},{"facility":46,"status":73,"city":106,"state":107,"zip":11,"country":50,"countryCode":51,"cosmosGeoPoint":108,"geoPoint":112,"contacts":113},"Guangzhou","Guangdong",{"type":53,"coordinates":109},[110,111],113.25,23.11667,{"lat":111,"lon":110},[114,115],{"name":40,"role":41,"phone":60,"phoneExt":11,"email":43},{"name":11,"role":41,"phone":11,"phoneExt":11,"email":43},{"facility":46,"status":73,"city":117,"state":107,"zip":11,"country":50,"countryCode":51,"cosmosGeoPoint":118,"geoPoint":122,"contacts":123},"Shenzhen",{"type":53,"coordinates":119},[120,121],114.0683,22.54554,{"lat":121,"lon":120},[124,125],{"name":40,"role":41,"phone":60,"phoneExt":11,"email":43},{"name":11,"role":41,"phone":11,"phoneExt":11,"email":43},{"facility":46,"status":47,"city":127,"state":128,"zip":11,"country":50,"countryCode":51,"cosmosGeoPoint":129,"geoPoint":133,"contacts":134},"Nanning","Guangxi",{"type":53,"coordinates":130},[131,132],108.31667,22.81667,{"lat":132,"lon":131},[135],{"name":40,"role":41,"phone":60,"phoneExt":11,"email":43},{"facility":46,"status":73,"city":137,"state":138,"zip":11,"country":50,"countryCode":51,"cosmosGeoPoint":139,"geoPoint":143,"contacts":144},"Zhengzhou","Henan",{"type":53,"coordinates":140},[141,142],113.64861,34.75778,{"lat":142,"lon":141},[145,146],{"name":40,"role":41,"phone":60,"phoneExt":11,"email":43},{"name":11,"role":41,"phone":11,"phoneExt":11,"email":43},{"facility":46,"status":73,"city":148,"state":149,"zip":11,"country":50,"countryCode":51,"cosmosGeoPoint":150,"geoPoint":154,"contacts":155},"Changzhou","Jiangsu",{"type":53,"coordinates":151},[152,153],119.95401,31.77359,{"lat":153,"lon":152},[156,157],{"name":40,"role":41,"phone":60,"phoneExt":11,"email":43},{"name":11,"role":41,"phone":11,"phoneExt":11,"email":43},{"facility":46,"status":73,"city":159,"state":160,"zip":11,"country":50,"countryCode":51,"cosmosGeoPoint":161,"geoPoint":165,"contacts":166},"Chengdu","Sichuan",{"type":53,"coordinates":162},[163,164],104.06667,30.66667,{"lat":164,"lon":163},[167,168],{"name":40,"role":41,"phone":60,"phoneExt":11,"email":43},{"name":11,"role":41,"phone":11,"phoneExt":11,"email":43},{"facility":46,"status":73,"city":170,"state":171,"zip":11,"country":50,"countryCode":51,"cosmosGeoPoint":172,"geoPoint":176,"contacts":177},"Hangzhou","Zhejiang",{"type":53,"coordinates":173},[174,175],120.16142,30.29365,{"lat":175,"lon":174},[178,179],{"name":40,"role":41,"phone":60,"phoneExt":11,"email":43},{"name":11,"role":41,"phone":11,"phoneExt":11,"email":43},{"type":181,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR","100603545","phase-2-a-study-to-evaluate-the-efficacy-and-safety-of-ahb-137-injection-in-participants-with-chronic-hepatitis-b-chb-100603545",false,"NCT07137910","A Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB)","An Open-Label, Multicenter, Phase 2 Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Participants With Low-HBsAg Chronic Hepatitis B","Inclusion Criteria:\n\n* Voluntarily participate in the study and sign the informed consent form;\n* 18-65 years of age (including boundary values) ;\n* Body mass index met the requirements;\n* Participants with CHB who are HBsAg or HBV DNA positive for at least 6 months;\n* Meet the relevant requirements for prior medications;\n* HBsAg and HBV DNA and liver function indicators meet the requirements;\n* Effective contraception as required;\n\nExclusion Criteria:\n\n* Uncontrolled and stable clinically significant abnormalities other than a history of CHB infection;\n* Associated liver disease;\n* Any serious infection other than CHB infection requires intravenous anti-infective therapy;\n* HCV RNA positive, HIV antibody positive, syphilis positive;\n* Abnormal laboratory results;\n* Diseases associated with vascular inflammatory conditions;\n* QT interval corrected heart rate (Fridericia method) abnormal;\n* History of malignancy or ongoing assessment of possible malignancy;\n* History of allergies, or allergic constitution;\n* Participants with recent major trauma or major surgery, or planning surgery;\n* Those who are participating in another clinical trial, or have not undergone a protocol-specified washout period prior to this study;\n* Prior\u002Fcurrent use of prohibited medications;\n* Inappropriate for participation in this trial as judged by the investigator.","ALL","18 Years","65 Years",{"count":193,"type":194},200,"ESTIMATED","INTERVENTIONAL",[197],"PHASE2","This is an open-label, multicenter, Phase 2 study designed to evaluate the efficacy and safety of AHB-137 injection in participants with chronic hepatitis B (CHB) with low hepatitis B surface antigen (HBsAg) levels.",[200],"Chronic Hepatitis B",[202],"Hepatitis B, Chronic","2026-08-03",{"date":205,"type":206},"2026-08-05","ACTUAL",{"date":208,"type":206},"2025-09-04",{"date":210,"type":194},"2027-06-01",{"name":5,"class":6},12]